Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case seriesBaptiste Hoellinger, Yvon Ruch, Célestine Simand et al.|Clinical Microbiology and Infection|2022Cited by 25
Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC β-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective studyBaptiste Hoellinger, Axel Ursenbach, Charlotte Kaeuffer et al.|International Journal of Infectious Diseases|2023Cited by 17
Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort StudyBaptiste Hoellinger, Y. Hansmann, Nicolas Lefèbvre et al.|Microbiology Spectrum|2022Cited by 16
Suppressive antibiotic therapy for infectious endocarditisT. Lemmet, Yvon Ruch, M. Bourne-Watrin et al.|Infectious Diseases Now|2024Cited by 13
Impact of 16S rDNA sequencing on clinical treatment decisions: a single center retrospective studyAxel Ursenbach, X. Argémi, Frédéric Schramm et al.|BMC Infectious Diseases|2021Cited by 11